On September 25, 2023, a groundbreaking new drug, lecanemab (Leyibao), jointly developed by Weicai/Bojian, targeting early-stage Alzheimer's disease patients, was approved in Lecheng, Boao, Hainan.

The second "Zhiyin Cloud" venture capital competition focuses on the "1+6" modern industrial system in Hanyang, selecting excellent innovation seeds nationwide, linking capital and enterprises, and achieving innovation fusion. This year's competition has launched the "Fund Doubling" plan, inviting provincial and municipal investment platforms and well-known market-oriented investment institutions to establish on-site "Fund Observation Teams" to participate in the selection and investment of excellent projects throughout the process, and will provide more than double the funding support for award-winning enterprises. The competition sets up a youth entrepreneurship track to attract outstanding young people and high-quality projects to come to and stay in Hanyang.

In China, starting from October 1st, etomidate has been officially listed in the second category of psychotropic drugs, and illegal trafficking and consumption of etomidate are considered illegal and criminal acts. Drug users abuse etomidate mainly by adding it to the tobacco or e-liquid of cigarettes for smoking. Since October, the police in Yuzhong, Chongqing have cracked two consecutive cases of drug trafficking in e-cigarettes containing etomidate. Cigarettes containing this ingredient are not allowed to touch e-cigarettes!